Each year, Brain Tumor Awareness Day serves as a critical reminder of the challenges faced by brain cancer patients, and the urgent need for continued research, innovation, and advocacy. At Plus Therapeutics, we are proud to stand alongside passionate individuals and organizations who are driving progress in the fight against brain tumors.
One such partner is Shannon Traphagen, host of the powerful Game On Glio podcast. A voice of strength, resilience, and advocacy, Shannon is helping to amplify the stories of glioblastoma (GBM) patients and caregivers, while creating space for education and community within the brain tumor world. Her work is instrumental in bridging the gap between research and the people it’s meant to help.
As part of our shared mission to improve outcomes for brain tumor patients, Plus Therapeutics is currently enrolling eligible patients in the Phase 2 RESPECT-GBM clinical trial, which is investigating a targeted treatment option for individuals diagnosed with glioblastoma. GBM is one of the most aggressive forms of brain cancer, and innovative treatments are urgently needed.
If you or someone you know is living with GBM and may qualify for the trial, we encourage you to explore the study details on our website: RESPECT-GBM Clinical Trial. You can also contact us directly at respect@plustherapeutics.com for more information.
In the spirit of awareness and action, we also invite you to listen to the new season of the Game On Glio podcast, available on all major streaming platforms. Each episode sheds light on the patient experience, emerging science, and the hope driving this community forward.
#BrainTumorAwareness #Glioblastoma #GBM #BrainCancer #ClinicalTrials #OncologyResearch #PatientAdvocacy #GameOnGlio #PlusTherapeutics #HopeForGBM #BrainTumorCommunity
Recent Comments